Skip to main content Accessibility help
  • Print publication year: 2011
  • Online publication date: December 2011

Chapter 3 - Intra-operative management

from Section 1 - General considerations


1. TungA. Anaesthetic considerations with the metabolic syndrome. Br J Anaesth 2010; 105 Suppl 1: i24–i33.
2. AfolabiBA, NovaroGM, SzomsteinS, RosenthalRJ, AsherCR. Cardiovascular complications of obesity surgery in patients with increased preoperative cardiac risk. Surg Obes Relat Dis 2009; 5: 653–656.
3. KalfarentzosF, StavropoulouF, YarmenitisSet al. Prophylaxis of venous thromboembolism using two different doses of low-molecular-weight heparin (nadroparin) in bariatric surgery: a prospective randomized trial. Obes Surg 2001; 11: 670–676.
4. FreidEB. The rapid sequence induction revisited: obesity and sleep apnea syndrome. Anesthesiol Clin North Am 2005; 23: 551–564.
5. HarterRL, KellyWB, KramerMG, PerezCE, DzwonczykRR. A comparison of the volume and pH of gastric contents of obese and lean surgical patients. Anesth Analg 1998; 86: 147–152.
6. JuvinP, FèvreG, MeroucheM, VallotT, DesmontsJM. Gastric residue is not more copious in obese patients. Anesth Analg 2001; 93: 1621–1622.
7. MaltbyJR, PytkaS, WatsonNC, CowanRA, FickGH. Drinking 300 mL of clear fluid two hours before surgery has no effect on gastric fluid volume and pH in fasting and non-fasting obese patients. Can J Anaesth 2004; 51: 111–115.
8. OttestadE, SchmiessingC, Brock-UtneJGet al. Central venous access in obese patients: a potential complication. Anesth Analg 2006; 102: 1293–1294.
9. LemmensHJ, BrodskyJB. General anesthesia, bariatric surgery, and the BIS monitor. Obes Surg 2005; 15: 63.
10. CollinsJS, LemmensHJ, BrodskyJB, Brock-UtneJG, LevitanRM. Laryngoscopy and morbid obesity: a comparison of the “sniff” and “ramped” positions. Obes Surg 2004; 14: 1171–1175.
11. BoyceJR, NessT, CastromanP, GleysteenJJ. A preliminary study of the optimal anesthesia positioning for the morbidly obese patient. Obes Surg 2003; 13: 4–9.
12. JenseHG, DubinSA, SilversteinPI, O'Leary-EscolasU. Effect of obesity on safe duration of apnea in anesthetized humans. Anesth Analg 1991; 72: 89–93.
13. AltermattFR, MuñozHR, DelfinoAE, CortínezLI. Pre-oxygenation in the obese patient: effects of position on tolerance to apnoea. Br J Anaesth 2005; 95: 706–709.
14. GanderS, FrascaroloP, SuterM, SpahnDR, MagnussonL. Positive end-expiratory pressure during induction of general anesthesia increases duration of nonhypoxic apnea in morbidly obese patients. Anesth Analg 2005; 100: 580–584.
15. BrodskyJB, LemmensHJ, Brock-UtneJG, VierraM, SaidmanLJ. Morbid obesity and tracheal intubation. Anesth Analg 2002; 94: 732–736.
16. GrantSA, BreslinDS, MacLeodDB, GleasonD, MartinG. Dexmedetomidine infusion for sedation during fiberoptic intubation: a report of three cases. J Clin Anesth 2004; 16: 124–126.
17. KellerC, BrimacombeJ, KleinsasserA, BrimacombeL. The Laryngeal Mask Airway ProSeal(TM) as a temporary ventilatory device in grossly and morbidly obese patients before laryngoscope-guided tracheal intubation. Anesth Analg 2002; 94: 737–740.
18. SprungJ, WeingartenTN, WarnerDO. Ventilatory strategies during anesthesia. In Morbid Obesity: Peri-operative Management, 2nd edition. AlvarezA, BrodskyJB, LemmensHJM, MortonJ (Eds.), pp. 124–137. Cambridge: Cambridge University Press, 2010.
19. BernsteinDP. Cardiovascular physiology. In Morbid Obesity: Peri-operative Management, 2nd edition. AlvarezA, BrodskyJB, LemmensHJM, MortonJ (Eds.), pp. 1–18. Cambridge: Cambridge University Press, 2010.